These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26934555)

  • 21. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
    Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
    Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma.
    Tanaka R; Kageyama K; Kimura K; Eguchi S; Tauchi J; Shinkawa H; Ohira GO; Yamazoe S; Yamamoto A; Tanaka S; Amano R; Tanaka H; Yashiro M; Kubo S; Ohira M
    Anticancer Res; 2020 May; 40(5):2637-2644. PubMed ID: 32366408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
    Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC
    Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse Models of Pancreatic Ductal Adenocarcinoma.
    Ponz-Sarvise M; Tuveson DA; Yu KH
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):609-17. PubMed ID: 26226900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
    Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Patient-Derived Tumor Xenograft Models.
    Annibali D; Leucci E; Hermans E; Amant F
    Methods Mol Biol; 2019; 1862():217-225. PubMed ID: 30315470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis.
    Wang X; Gao J; Ren Y; Gu J; Du Y; Chen J; Jin Z; Zhan X; Li Z; Huang H; Lv S; Gong Y
    Am J Gastroenterol; 2011 Dec; 106(12):2104-11. PubMed ID: 21876563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic Ultrasound-Guided Fine-Needle Biopsies to Generate Preclinical Disease Models to Study Inflammation in Pancreatic Ductal Adenocarcinoma.
    Lundy J; Croagh D
    Methods Mol Biol; 2023; 2691():43-54. PubMed ID: 37355536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.
    Purohit A; Varney M; Rachagani S; Ouellette MM; Batra SK; Singh RK
    Oncotarget; 2016 Feb; 7(6):7280-96. PubMed ID: 26771140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized RNA Medicine for Pancreatic Cancer.
    Gilles ME; Hao L; Huang L; Rupaimoole R; Lopez-Casas PP; Pulver E; Jeong JC; Muthuswamy SK; Hidalgo M; Bhatia SN; Slack FJ
    Clin Cancer Res; 2018 Apr; 24(7):1734-1747. PubMed ID: 29330203
    [No Abstract]   [Full Text] [Related]  

  • 32. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
    Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
    J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells.
    Ischenko I; Petrenko O; Hayman MJ
    Oncotarget; 2015 Jun; 6(18):15814-27. PubMed ID: 26158412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    Cancer Lett; 2020 Jul; 481():63-75. PubMed ID: 32145343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer.
    Witkiewicz AK; Balaji U; Eslinger C; McMillan E; Conway W; Posner B; Mills GB; O'Reilly EM; Knudsen ES
    Cell Rep; 2016 Aug; 16(7):2017-31. PubMed ID: 27498862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
    Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor.
    Gayet O; Loncle C; Duconseil P; Gilabert M; Lopez MB; Moutardier V; Turrini O; Calvo E; Ewald J; Giovannini M; Gasmi M; Bories E; Barthet M; Ouaissi M; Goncalves A; Poizat F; Raoul JL; Secq V; Garcia S; Viens P; Dusetti N; Iovanna J
    Oncotarget; 2015 Jan; 6(2):746-54. PubMed ID: 25481873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma.
    Haney SL; Varney ML; Chhonker YS; Shin S; Mehla K; Crawford AJ; Smith HJ; Smith LM; Murry DJ; Hollingsworth MA; Holstein SA
    Oncogene; 2019 Jun; 38(26):5308-5320. PubMed ID: 30918331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.
    Siddique HR; Liao DJ; Mishra SK; Schuster T; Wang L; Matter B; Campbell PM; Villalta P; Nanda S; Deng Y; Saleem M
    Int J Cancer; 2012 Oct; 131(7):1720-31. PubMed ID: 22190076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.
    Stellas D; Szabolcs M; Koul S; Li Z; Polyzos A; Anagnostopoulos C; Cournia Z; Tamvakopoulos C; Klinakis A; Efstratiadis A
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25306215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.